ASCO 2024: Lung cancer highlights

More effective treatment options required for patients with MM post lenalidomide exposure

Lower levels of inflammatory markers and tumour burden is linked to improvements in PFS with Ide-Cel in R/R multiple myeloma

Isatuximab in combination with pomalidomide and dexamethasone shows promising efficacy in 2nd line RRMM

PD-1–refractory advanced melanoma: how do we get to the finish line?

Highlights in melanoma from ASCO 2024

Encouraging results using mismatched unrelated donors in stem cell transplantation

Trastuzumab deruxtecan significantly improves PFS In breast cancer patients previously treated with endocrine therapy

Quality of life and patient satisfaction of Filipinos after breast conservation surgery and intraoperative radiotherapy

ASCO 2024: Highlights and analysis

Inavolisib, palbociclib, fulvestrant combo shows sustained benefit beyond disease progression in HER2‑negative metastatic breast cancer

Lutetium-177–PSMA-617 improves self-reported pain and HRQoL in taxane-naïve patients with PSMA-positive mCRPC